SCHEDULE 13G/A: Adage Capital Management Discloses 2.77% Passive Stake in UroGen Pharma Ltd.
Beneficial Ownership Report
Adage Capital Management, L.P., along with Robert Atchinson and Phillip Gross, has filed an amendment to their Schedule 13G, reporting a passive beneficial ownership of 2.77% in UroGen Pharma Ltd.'s Ordinary Shares as of March 31, 2025.
Summary
- Adage Capital Management, L.P., Robert Atchinson, and Phillip Gross collectively reported beneficial ownership of 1,277,000 Ordinary Shares of UroGen Pharma Ltd.
- This ownership represents 2.77% of UroGen Pharma Ltd.'s outstanding Ordinary Shares.
- The percentage is calculated based on 46,094,352 Ordinary Shares outstanding as of March 3, 2025, as reported in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed on March 10, 2025.
- The filing is an Amendment No. 2 to Schedule 13G, indicating a passive investment purpose, meaning the Reporting Persons do not intend to influence or change control of the issuer.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would indicate positive or negative sentiment regarding the issuer's performance or outlook.
Positives
- NA
Negatives
- NA
Risks
- NA
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: Provides transparency regarding a significant institutional investor's passive stake in the company, which can influence market perception of institutional interest.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date as of which 46,094,352 Ordinary Shares of UroGen Pharma Ltd. were reported outstanding in the Company's 10-K filing. |
| 03/10/2025 | Date UroGen Pharma Ltd. filed its Annual Report on Form 10-K for the fiscal year ended December 31, 2024. |
| 03/31/2025 | Date of event which requires the filing of this statement (reporting period end date for ownership). |
| 05/12/2025 | Filing date of this Schedule 13G Amendment No. 2. |
Keywords
UroGen Pharma Ltd., Adage Capital Management, SEC filing, Schedule 13G, beneficial ownership, ordinary shares, passive investment, institutional investor
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.